Key result
Cardiac magnetic resonance and cardiac computed tomography are valuable noninvasive imaging methods for the diagnosis, prognosis, and management of hypertrophic cardiomyopathy.
Why the study?
What is the role of cardiac magnetic resonance and computed tomography in the diagnosis and prognosis of hypertrophic cardiomyopathy?
What is the role of cardiac magnetic resonance and computed tomography in the diagnosis and prognosis of hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
CMR and CCT provide high sensitivity and specificity for the diagnosis, prognosis, and management of hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease and represents the main cause of sudden death in young patients. Cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT) are noninvasive imaging methods with high sensitivity and specificity, useful for the establishment of diagnosis and prognosis of HCM, and for the screening of patients with subclinical phenotypes. The improvement of image analysis by CMR and CCT offers the potential to promote interventions aiming at stopping the natural course of the disease. This study aims to describe the role of RCM and CCT in the diagnosis and prognosis of HCM, and how these methods can be used in the management of these patients.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2016) conducted a review in Hypertrophic cardiomyopathy. Cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT) was evaluated. Cardiac magnetic resonance and cardiac computed tomography are valuable noninvasive imaging methods for the diagnosis, prognosis, and management of hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: